155 related articles for article (PubMed ID: 22684422)
1. Correlates of susceptibility to hepatitis B among people who inject drugs in Sydney, Australia.
Deacon RM; Topp L; Wand H; Day CA; Rodgers C; Haber PS; van Beek I; Maher L
J Urban Health; 2012 Oct; 89(5):769-78. PubMed ID: 22684422
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus exposure and vaccination in a cohort of people who inject drugs: what has been the impact of targeted free vaccination?
Winter RJ; Dietze PM; Gouillou M; Hellard ME; Robinson P; Aitken CK
J Gastroenterol Hepatol; 2013 Feb; 28(2):314-22. PubMed ID: 23190264
[TBL] [Abstract][Full Text] [Related]
3. A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia.
Topp L; Day CA; Wand H; Deacon RM; van Beek I; Haber PS; Shanahan M; Rodgers C; Maher L;
Prev Med; 2013 Oct; 57(4):297-303. PubMed ID: 23639625
[TBL] [Abstract][Full Text] [Related]
4. A large proportion of people who inject drugs are susceptible to hepatitis B: Results from a bio-behavioural study in eight German cities.
Haussig JM; Nielsen S; Gassowski M; Bremer V; Marcus U; Wenz B; Bannert N; Bock CT; Zimmermann R;
Int J Infect Dis; 2018 Jan; 66():5-13. PubMed ID: 29097248
[TBL] [Abstract][Full Text] [Related]
5. Development of immunity following financial incentives for hepatitis B vaccination among people who inject drugs: A randomized controlled trial.
Day CA; Shanahan M; Wand H; Topp L; Haber PS; Rodgers C; Deacon R; Walsh N; Kaldor J; van Beek I; Maher L;
J Clin Virol; 2016 Jan; 74():66-72. PubMed ID: 26679830
[TBL] [Abstract][Full Text] [Related]
6. Association between universal hepatitis B prison vaccination, vaccine uptake and hepatitis B infection among people who inject drugs.
Palmateer NE; Goldberg DJ; Munro A; Taylor A; Yeung A; Wallace LA; Mitchell A; Shepherd SJ; Gunson RN; Aitken C; Hutchinson SJ
Addiction; 2018 Jan; 113(1):80-90. PubMed ID: 28710874
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis A and B among young persons who inject drugs--vaccination, past, and present infection.
Collier MG; Drobeniuc J; Cuevas-Mota J; Garfein RS; Kamili S; Teshale EH
Vaccine; 2015 Jun; 33(24):2808-12. PubMed ID: 25889161
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus among injecting drug users in Sydney, Australia: prevalence, vaccination and knowledge of status.
Day CA; White B; Dore GJ; van Beek I; Rodgers C; Cunningham P; Wodak A; Maher L
Drug Alcohol Depend; 2010 Apr; 108(1-2):134-7. PubMed ID: 20047803
[TBL] [Abstract][Full Text] [Related]
9. Are there missed opportunities for vaccinating against hepatitis B among people who inject drugs in the UK?
Njoroge J; Hope VD; O'Halloran C; Edmundson C; Glass R; Parry JV; Ncube F
Epidemiol Infect; 2019 Jan; 147():e244. PubMed ID: 31364574
[TBL] [Abstract][Full Text] [Related]
10. Vaccination against hepatitis B virus among people who inject drugs - A 20year experience from a Swedish needle exchange program.
Alanko Blomé M; Björkman P; Flamholc L; Jacobsson H; Widell A
Vaccine; 2017 Jan; 35(1):84-90. PubMed ID: 27894721
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B and C in New South Wales prisons: prevalence and risk factors.
Butler TG; Dolan KA; Ferson MJ; McGuinness LM; Brown PR; Robertson PW
Med J Aust; 1997 Feb; 166(3):127-30. PubMed ID: 9059433
[TBL] [Abstract][Full Text] [Related]
12. Acceptance and completion of hepatitis B vaccination among drug users in New York City.
Ompad DC; Galea S; Wu Y; Fuller CM; Latka M; Koblin B; Vlahov D
Commun Dis Public Health; 2004 Dec; 7(4):294-300. PubMed ID: 15779793
[TBL] [Abstract][Full Text] [Related]
13. Outcome of a hepatitis B vaccination program for clients of a drug consumption facility.
Scherbaum N; Timm J; Richter F; Bonnet U; Bombeck J; Lajos S; Specka M
J Clin Virol; 2018 Sep; 106():28-32. PubMed ID: 30015286
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C testing and status among opioid substitution treatment clients in New South Wales.
Shand FL; Day C; Rawlinson W; Degenhardt L; Martin NG; Nelson EC
Aust N Z J Public Health; 2014 Apr; 38(2):160-4. PubMed ID: 24690055
[TBL] [Abstract][Full Text] [Related]
15. The Potential Reach of Opioid Substitution Settings to Deliver HCV Care to People Who Inject Drugs in Australia.
Butler K; Day C; Dietze P; Bruno R; Alati R; Burns L
J Subst Abuse Treat; 2015 Nov; 58():90-4. PubMed ID: 26117080
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US cities.
Bowman S; Grau LE; Singer M; Scott G; Heimer R
BMC Public Health; 2014 Aug; 14():820. PubMed ID: 25107530
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and correlates of previous hepatitis B vaccination and infection among young drug-users in New York City.
Amesty S; Ompad DC; Galea S; Fuller CM; Wu Y; Koblin B; Vlahov D
J Community Health; 2008 Jun; 33(3):139-48. PubMed ID: 18185987
[TBL] [Abstract][Full Text] [Related]
18. WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs.
Walsh N; Verster A; Rodolph M; Akl EA
Int J Drug Policy; 2014 May; 25(3):363-71. PubMed ID: 24561223
[TBL] [Abstract][Full Text] [Related]
19. Adherence to hepatitis B virus vaccination at syringe exchange sites.
Altice FL; Bruce RD; Walton MR; Buitrago MI
J Urban Health; 2005 Mar; 82(1):151-61. PubMed ID: 15746385
[TBL] [Abstract][Full Text] [Related]
20. Service utilization and cost of implementing a comprehensive HIV prevention and care program among people who inject drugs in Delhi, India.
Sebastian MP; Dasgupta A; Saraswati LR; Singh A; Sharma V; Madan I; Tun W; Pulerwitz J; Thior I; Sarna A
Harm Reduct J; 2017 Jun; 14(1):38. PubMed ID: 28615077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
